![Kiyoshi Eshima](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 660 375 $ au 30/06/2026
Kiyoshi Eshima is the founder of Delta-Fly Pharma, Inc. which is founded in 2010, where he currently holds the title of President & Representative Director.
He previously worked at Taiho Pharmaceutical Co., Ltd. as Director & Manager-Tokushima Research Center.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DELTA-FLY PHARMA, INC. 5,85 % | 19/01/2026 | 832 000 ( 5,85 % ) | 660 375 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DELTA-FLY PHARMA, INC. | Fondateur | 06/12/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Commercial Services |
Delta-Fly Pharma, Inc.
 Delta-Fly Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the bio-pharmaceutical development business | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
